Our path to success
Master & Fellow

A new strategy

Medical research has demonstrated the therapeutic efficacy of intracranial endovascular treatments for stroke management. For hemorrhagic strokes, such as ruptured cerebral aneurysms, minimally invasive management reduces the neurological morbidity of the procedures and improves the rate of functional recovery compared with surgical treatments (ISAT Study, Lancet 2002).

This new strategy now allows a preventive approach to aneurysmal ruptures in at-risk populations. In addition to this hemorrhagic activity, physicians have also been managing ischemic strokes by occlusion of the large trunks since the publication of the MR CLEAN study in 2015 (Mr. Clean investigators, A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke, New England journal of medicine, 2015), which demonstrated the superiority of the endovascular approach combined with treatment by medicated fibrinolytics.

As a result, a large need for training in endovascular treatment techniques has emerged worldwide to accompany these substantial therapeutic evolutions. It is with this observation in mind that the Stroke Live Course (SLICE) was born in 2015. The first five editions were held in a classic congress format. They took place in Nice (France) and gathered, each year, more than 300 specialists from all over the world. In 2020, SLICE was transformed into a free televised and on-demand program in order to widen its reach to healthcare professionals from all over the world. Today, SLICE has an audience that is located mainly in China, India, and the USA, followed closely by Europe and North Africa. SLICE's vocation being international, the content is multi-lingual – notably, in English and Chinese.

SLICE has become an innovative digital platform of know-how and best practices, available online for free and on demand, for any healthcare professional worldwide: Workflow simulations, Serious Games, Tutorials, Best Techniques, Educational and instructional videos… (https://masterandfellow.com)

SLICE is composed of two annual events: "SLICE Next Frontiers" in April, centered around the theme of hemorrhage, and "SLICE Worldwide" in October, centered around the theme of ischemia. Each event is articulated around three key moments:

• A TV show that welcomes different specialists to debate and to share their experiences. The show is livestreamed over two days: eight hours a day, with different sections and, as a common thread, simulations on silicone models from real clinical cases that are broadcast live from operating rooms.
• Living Labs: meetings between key opinion leaders and industry players whose objective is to gather user feedback on medical devices.
• Workshops for healthcare professionals, from all over the world and of all generations, to improve practices. Throughout the year, these workshops can also be organized at the request of our partners anywhere in the world.

Starting in 2023, SLICE will also be developing a Web TV that will allow the content of both annual SLICE events to be supported dynamically throughout the year.

SLICE is a scientific manifestation with an international vocation that promotes innovation for physicians, and for the entire healthcare chain. It is an event of highly added value, based on the articulation of clinical, academic, and medical device industry expertise for the benefit of all players and patient expectations. SLICE's main objective is to promote multi-field innovations through the sharing of practical intelligence.

As a result

Master & Fellow, which produces SLICE, is a third-party company or a third-party medical device law firm. It has committed itself to a compliance process. 

In its contractual relations with its industrial partners, the company follows the deontological and ethical standards produced by the dedicated regulatory organizations:

1. The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
2. The European Federation of Pharmaceutical Industries and Associations (EFPIA)
3. The « Comité d’éthique et de déontologie des entreprises de Médicament en France » (CODEEM), or the Deontology and Ethics Committee for Pharmaceutical Companies in France.

Master & Fellow implements these standards in the organization and conduct of SLICE, and in all its distribution mediums.

Master & Fellow encourages each person to fulfill their obligations regarding the rules for preventing, managing, and declaring links of interest.

Master & Fellow thus promotes a participatory ethic of co-responsibility with industry players, with the participants (experts), and with the public.

Each and every one of them makes the collective success of SLICE, its value, and its durability. We would like to thank each and every one of them.

What's next ?

SLICE:

- Promotes public health and facilitates internationally improving the management of cerebrovascular pathologies. 

- Contributes to the implementation of official recommendations of good practices.

- Participates in an internationally concerted vigilance when it comes to equipment.

- Allows for an analysis of clinical practices and their improvements.

- Is an observatory for the use of medical devices.

- Facilitates an improvement of their use through feedback from users.

- Promotes quality of care and fights against medical errors.

- Highlights the efficiency of the chain of care and of team management procedures.